ArticleRheumatology and therapy2022

A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.

Stanley Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.